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Abstract
Background  and  objective:  Pulmonary  embolism  (PE)  is  a  common  disease  with  variable  symp-
toms and  high  overall  mortality.  The  clinical  relevance  of  the  extent  of  PE  is  still  debatable,  and
the role  of  anticoagulation  in  patients  with  subsegmental  involvement  has  been  contested.  Our
objective is  to  describe  the  clinical  details  of  patients  with  PE  in  our  hospital  and  to  analyze
their prognosis  based  on  the  extent  of  the  disease.
Materials  and  methods:  Retrospective  study  of  313  patients  diagnosed  with  PE  by  chest  com-
puted tomography  (CT)  scan  at  the  Hospital  Complex  of  Pontevedra  in  Spain  for  six  years.
Predictors of  mortality  were  determined  by  multivariate  analysis.
Results: Women  accounted  for  56%  of  patients,  and  patient  median  age  was  70  years  (interquar-
tile range  53--78  years).  Subsegmental  PE  accounted  for  7%  of  all  cases;  these  patients  were
younger and  had  lower  comorbidity;  they  reported  chest  pain  more  often,  performed  better  in
blood gas  analysis  and  none  of  them  had  proximal  deep  vein  thrombosis  (DVT).  Patients  with
subsegmental  PE  had  a  higher  survival  rate.  Factors  independently  associated  with  mortality
were cancer  diagnosis  and  higher  comorbidity.
Conclusions:  Patients  with  subsegmental  PE  clinically  differ  from  those  with  more  proximal  PE.
Underlying  diseases  have  more  inﬂuence  on  the  prognosis  than  the  extent  of  the  disease.
© 2013  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.∗ Corresponding author.
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Resumo
Contexto  e  objectivo:  A  embolia  pulmonar  (PE)  é  uma  doenc¸a  comum  com  sintomas  variáveis
e uma  elevada  taxa  de  mortalidade  global.  A  relevância  clínica  da  extensão  da  PE  é  ainda  fonte
de debate,  e  o  papel  da  anticoagulac¸ão  em  pacientes  com  envolvimento  de  sub-segmentos  foi
contestado.  O  nosso  objectivo  é  descrever  os  dados  clínicos  de  doentes  com  PE  no  nosso  hospital
e analisar  o  seu  prognóstico,  com  base  na  extensão  da  doenc¸a.
Materiais  e  métodos:  Estudo  retrospectivo  de  313  doentes,  diagnosticados  com  PE,  através
de uma  tomograﬁa  computadorizada  de  tórax  (TC)  no  Complexo  Hospitalar  de  Pontevedra,
em Espanha,  durante  seis  anos.  Os  preditores  de  mortalidade  foram  determinados  por  análise
multivariada.
Resultados:  As  mulheres  representaram  56%  dos  doentes,  e  a  idade  média  era  de  70  anos  (ampli-
tude interquartis  53--78  anos).  A  PE  ao  nível  dos  sub-segmentos  era  responsável  por  7%  de  todos
os casos;  estes  doentes  eram  mais  jovens  e  tinham  uma  taxa  de  comorbidade  inferior;  referiram
dor torácica  com  maior  frequência,  tiveram  melhores  resultados  na  gasimetria  arterial  e  nen-
hum deles  sofreu  uma  trombose  venosa  profunda  (TVP)  proximal.  Os  doentes  com  PE  ao  nível
dos sub-segmentos  tiveram  uma  taxa  de  sobrevivência  mais  elevada.  Os  factores  associados  de
modo independente  com  a  mortalidade  foram  o  diagnóstico  de  cancro  e  uma  comorbidade  mais
elevada.
Conclusões:  Os  doentes  com  PE  ao  nível  dos  sub-segmentos  diferem  clinicamente  daqueles  com
PE proximal.  No  prognóstico,  as  doenc¸as  subjacentes  têm  maior  inﬂuência  que  a  extensão  da
doenc¸a.
© 2013  Sociedade  Portuguesa  de  Pneumologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
direitos reservados.
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2Introduction
Pulmonary  embolism  (PE)  is  a  common  disease  with  an
annual  incidence  of  110  cases  per  100,000  adults,1 which
has  been  increasing  over  recent  years.1,2 Symptoms  may
vary,  from  asymptomatic  to  obstructive  shock  following  cir-
culatory  collapse.3 Overall  mortality  is  not  only  high,  but
also  highly  variable.  In  a  recent  study,  overall  mortality
was  8.65%  at  three  months.4 Central  arteries  are  most  com-
monly  involved,5,6 while  subsegmental  PE  accounts  for  4--7%
cases.7--9 However,  a  number  of  studies  report  subsegmental
involvement  in  up  to  30%  patients.9
The  clinical  relevance  of  the  extent  of  PE  is  still  debat-
able,  and  the  role  of  anticoagulation  in  patients  with
subsegmental  involvement  has  been  contested  in  a  number
of  studies.10,11
The  objective  of  our  study  was  to  describe  the  clinical
particulars  of  patients  with  PE  in  our  hospital  and  to  analyze
their  prognosis  based  on  the  extent  of  the  disease.
Methods
We  conducted  a  retrospective  study  of  all  patients  above
18  years  of  age  with  conﬁrmed  CT  chest  scan  diagnosis  of
PE12 at  the  Hospital  Complex  of  Pontevedra  in  Spain  between
January  2005  and  December  2010.  Follow-up  ended  on  Jan-
uary  31,  2012,  the  survival  deadline.  Thus,  the  minimum
follow-up  was  14  months.  Administrative  data  from  coded
hospital  discharges  were  used  for  patient  selection.  Those
patients  with  incomplete  data  and/or  diagnosis  made  by
methods  other  than  chest  CT  scan  were  excluded  from  thenitial  470  patient  sample.  Thus,  313  cases  were  included  in
he  study.
The  following  data  were  analyzed:
.  Personal  details:  age,  gender,  active  smoking  and  obesity
(body  mass  index  >30).
.  Clinical,  physical  examination  and  additional  test  data:
recent  surgery,  anesthesia,  trauma,  cancer,  prolonged
travel  and/or  immobilization;  lower  limb  paralysis;
insertion  of  central  catheter,  thrombophilia  or  antiphos-
pholipid  syndrome;  previous  venous  thromboembolic
disease  (VTE);  lower-limb  varicose  veins;  pregnancy,
contraception  or  hormone  therapy.  Tachypnea,  crepi-
tant  rale,  signs  of  lower-limb  DVT;  vital  signs,  systolic
hypotension  (SBP  <  100  mmHg),  diastolic  hypotension
(DBP  <  60  mmHg)  and  tachycardia  (heart  rate  >  100).13,14
Arterial  blood  gas  analysis,  hemoglobin,  hematocrit,
platelet  count,  leukocytosis,  neutrophilia,  glucose,  urea,
creatinine,  sodium,  potassium  and  ﬁbrinogen,  stratiﬁed
as  normal  or  abnormal  as  per  the  laboratory  reference
values  in  our  hospital.  D-dimer  levels  were  deter-
mined  with  high-sensitivity  turbidimetric  immunoassay.
D-dimer  levels  above  500  ng/ml  were  considered  patho-
logical.  Renal  function  was  considered  normal  with
glomerular  ﬁltration  rate  as  per  the  abbreviated
MDRD  equation  above  60  ml/min/1.73  m2.15 Electrocar-
diographic  and  imaging  ﬁndings:  plain  chest  radiograph;
lower-limb  echo-Doppler  (complete  or  distal)  was  per-
formed  at  the  discretion  of  the  radiologist,  based  on
patient  clinical  presentation.  PEs  were  collected  and
classiﬁed  into  three  groups  with  chest  CT  scanning:
central  (main  trunk,  right  or  left  pulmonary  artery,
1 M.T.  García-Sanz  et  al.
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Figure  1  Overall  survival  rates  and  extend  of  PE.
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intermediate  arteries  or  lobar  arteries),  segmental
and  subsegmental.  Thrombus  location  was  determined
according  to  the  largest  artery  involved.  Comorbidity
measured  by  the  Charlson  index  (CCI),  categorized  into
‘‘0’’,  ‘‘1--2’’  and  ‘‘≥3’’.16
.  Clinical  probability  was  determined  with  the  Wells17 and
Geneva18 scores.
.  Cause  of  death  was  attributed  by  the  main  investigator
based  on  available  medical  records  and  categorized  into
three  groups:  PE-related,  PE-unrelated,  and  unknown.
Discordance  between  data  and  uncertain  ﬁnal  diagnoses
was  resolved  by  discussion  with  data  collectors.
tatistical analysis
ategorical  variable  data  are  presented  as  frequencies  (per-
ents);  continuous  variable  data  are  presented  as  medians
nd  interquartile  ranges.
Fisher’s  exact  and  Chi-squared  tests  were  used  to  com-
are  categorical  variables.  Between  groups,  continuous
ariables  were  compared  by  ANOVA  or  the  Kruskal--Wallis
est  with  non-normal  distributions.
Survival  curves  and  increases  in  probability  of  death  were
espectively  calculated  with  the  Kaplan--Meier  test  and  the
ox  regression.  Differences  were  considered  signiﬁcant  at
 <  0.05.  Data  were  analyzed  with  SPSS  15  for  Windows.
esults
he  study  included  313  PE  patients;  56%  were  women
nd  the  median  age  was  70  years  (interquartile  range  53--
8  years).  Central  PE  accounted  for  68%  of  cases;  segmental
nd  subsegmental  PE,  for  25%  and  7%.  Patients  with  subseg-
ental  PE  were  younger,  had  lower  comorbidity  and  none
f  them  presented  proximal  DVT  (Table  1).  Patients  in  the
ubsegmental  PE  group  included  10  (45%)  with  single  PE  and
2  (55%)  with  multiple  PE.
As  for  symptoms,  dyspnea  is  the  most  common  one  in
atients  with  central  PE,  and  also  pain  is  common  in  segmen-
al  and  subsegmental  PE  (Table  1).  Comorbidity  measured  by
CI  was  present  in  78%  of  cases,  and  was  more  frequent  in
entral  PE  (Table  1).  22%  of  patients  had  been  diagnosed  with
ancer  prior  to  PE  (data  not  shown).  As  for  the  presence  of
isk  factors  and  the  clinical  probability  of  PE  according  to  the
ells  and  Geneva  scores,  no  differences  were  found  on
he  extent  of  the  disease  (Table  1).  As  for  the  additional
ests,  patients  with  central  artery  involvement  showed  sig-
iﬁcantly  higher  D-dimer  values  and  performed  poorer  in
lood  gas  analysis.  No  signiﬁcant  difference  was  found  in
ny  of  the  remaining  parameters  (Table  2).  All  patients  were
dmitted  to  the  hospital  and  treated  with  anticoagulants.
30-day  mortality  was  7%,  attributable  to  PE  in  3.5%  of
ases.  Patients  with  subsegmental  PE  showed  signiﬁcantly
igher  survival  rates  both  at  30  days  and  at  the  end  of  the
ollow-up  (Fig.  1).  No  difference  was  observed  in  the  cause
f  death  based  on  the  extent  of  PE  (Fig.  2).  Factors  inde-
endently  related  to  a  higher  likelihood  of  mortality  were
ancer  diagnosis  and  higher  comorbidity  measured  by  the
harlson  index  (Table  3).
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TFigure  2  Causes  of  death  and  extend  of  PE.
iscussion
revalence  of  subsegmental  PE  was  7%,  similar  to  that
eported  by  other  authors.5 No  signiﬁcant  gender  differ-
nce  was  found  in  terms  of  the  extent  of  the  disease;
owever,  the  proportion  of  women  is  slightly  higher  in  our
ample.  The  age  of  patients  with  subsegmental  PE  was
ower  than  that  of  patients  with  central  and  segmental  PE.
he  difference  could  be  related  to  hypercoagulation  and  the
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Table  1  Clinical  data  and  demographics  (n  =  313).
Total  (n  =  313) Central  (n  =  213)  Segmental  (n  =  78)  Subsegmental  (n  =  22)  p
Age  70(53--78)  71(56--79)  70.5(51.5--78)  55(38.35--71.5) *
Gender(male)  137(43.8%)  89(42%)  38(49%)  10(45.5%)  NS
Symptoms
Dyspnea 181(57.8%)  148(69.5%)  25(32%)  8(36.4%) *
Orthopnea  3(0.95%) 3(1.4%)  0(0%)  0(0%)  NS
Chest pain 132(42.2%) 80(37.6%) 40(51.3%)  12(54.5%) *
Pleuritic  pain 136(43.4%) 85(39.9%) 36(46.5%) 15(68.2%) *
Anginal  pain 28(8.9%) 23(10.8%) 4(5.1%) 1(4.5%) NS
L-limb  edema/pain  75(23.9%)  54(25.4%)  19(24.4%)  2(9%)  NS
Hemoptysis 15(4.8%)  7(3.3%)  6(7.7%)  2(9%)  NS
Cough 21(6.7%)  13(6%)  6(7.7%)  2(9%)  NS
Palpitations  18(5.75%)  15(7%)  2(2.6%)  1(4.5%)  NS
Syncope 38(12.1%)  31(14.6%)  4(5.1%)  3(13.6%)  NS
Proximal DVT  66(21%)  52(24.4%)  14(17.9%)  0(0%) **
Charlson **
=0  68(21.7%)  37(17.4%)  23(29.5%)  8(36.4%)
1--2 135(43.1%)  101(47.4%)  23(29.5%)  11(50%)
≥3 110(35.1%)  75(35.2%)  32(41%)  3(13.6%)
Cancer 68(21.7%)  47(69.1%)  19(27.9%)  2(2.9%)  NS
Probable PE  (Wells)  170(54.3%)  110(51.6%)  43(55%)  17(77.3%)  NS
Probable PE  (Geneva)  216(69%)  143(67%)  54(62.23%)  19(86.4%)  NS
NS = non-signiﬁcant.
Age as median and interquartile range.
* p < 0.05.
** p < 0.01.
Table  2  Additional  tests.
Central  (n  =  213)  Segmental  (n  =  78)  Subsegmental  p  (n  =  22)
Hemoglobin  13(11.7--14.1)  13.2(11.7--14.3)  13.4(12.3--14.5)  NS
Htc 39(35--40)  39(35.5--42.5)  40.5(37.7--42.7)  NS
Leukocytes 9400(7500--12,350)  9095(6675--12,100)  8650(6825--10,750)  NS
Neutrophils (%)  75(62.5--81)  75(66--83)  79(62--84)  NS
Platelets 232,000(184,750--285,500)  252,000(189,000--320,000)  238,500(190,750--267,250)  NS
Fibrinogen 535(430--689)  548(434--694)  465(395--590)  NS
D-dimer 3633(1977.5--5322.5,  n  =  62)  2230.7(1063--3124,  n  =  23)  1494(1104--1583,  n  =  6) *
Glucose  108(94--140)  103(90--129)  105(94--138)  NS
Normal renal  function  149(71%)  59(75.6%)  17(77.3%)  NS
Sodium 139(136--141)  133(136--139)  139(137--141)  NS
Potassium 4.3(4--4.6)  4.4(4.1--4.6)  4.5(4.2--4.7)  NS
SatO2 (21%)  92.7(88--94.7)  93.2(89.2--95.2)  95.4(94.1--96.4) *
pH  7.5(7.4--7.5)  7.5(7.4--7.5)  7.4(7.4--7.5)  NS
PO2 61(51--69)  65(53--72)  73(57--78) *
PCO2 34(30--38)  36(32--40)  35(32--40) *
Bicarbonate  23(21--25.6)  24.9(22.6--26.4)  24(22.3--26.8) **
Normal  chest  X-ray  116(54.4%)  39(50%)  13(59%)  NS
NS = non-signiﬁcant.
* p < 0.05.
** p < 0.01.
changes  in  vascular  endothelium  that  come  with  aging19:
these  could  facilitate  the  extent  of  thrombi  in  older
patients,  especially  considering  that  no  age  difference
was  found  in  the  prevalence  of  risk  factors  for
PE.
t
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pAlthough  symptoms  of  PE  are  nonspeciﬁc  and  presen-
ation  is  usually  similar  in  adults,  we  found  chest  pain
n  younger  patients  and  a  positive  association  between
ge  and  dyspnea.19 In  our  study,  chest  pain  in  younger
atients  with  peripheral  PE  and  dyspnea  in  older  patients
198  
Table  3  Predictors  of  mortality.  Multivariate  analysis.
Factors  OR  CI  95%
PE  location
Central  1
Segmental  1.28  0.79--2.09
Subsegmental  0.29  0.03--2.23
Cancer
No 1
Yes  3.72  2.30--6.03
Charlson
0 1
1--2 2.81 0.82--9.59
≥3  8.61  2.58--28.69
Adjusted by age, gender, renal function and blood gas parame-
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8. Ghaye B, Dondelinger RF. Non-traumatic thoracic emergen-
cies: CT venography in an integrated diagnosis strategy ofters.
ith  central  PE  and  higher  levels  of  hypoxia  were  most
ften  reported.  In  general,  dyspnea  occurred  less  frequently
n  patients  with  subsegmental  PE.10 These  performed
etter  in  blood  gas  analysis  and  had  an  overall  less
evere  clinical  presentation,20 including  lower  proximal
VT.5,10
D-dimer  levels  in  patients  with  PE  seems  to  be  associ-
ted  with  thrombus  size,  are  related  to  PE  severity  and  have
alue  as  prognostic  marker.21 We  found  lower  serum  levels
n  patients  with  subsegmental  PE,  who  had  a  more  benign
linical  presentation  and  a  better  mid-term  outcome.  How-
ver,  D-dimer  testing  was  only  carried  out  in  30%  of  cases.
hus,  our  results  are  not  conclusive.
In  our  study,  30-day  mortality  was  higher  than  in  other
tudies,22 although  the  proportion  of  PE-related  deaths  was
imilar.4 None  of  the  patients  died  as  a  result  of  subsegmen-
al  PE.  Differences  in  mortality  could  be  due  to  different
auses:  the  mean  age  of  our  patients  is  higher,  many  have
ccompanying  chronic  diseases  that  can  condition  the  bad
utcome  of  PE,  and  the  number  of  deaths  from  comorbidity
s  also  high.  In  fact,  the  most  important  determining  fac-
or  of  mortality  is  comorbidity,  especially  cancer.  Patients
ith  cancer  and  PE  not  only  have  a  bad  prognosis,  but  also
 worse  one  than  patients  with  only  cancer  or  PE.23 Symp-
oms  of  PE  could  be  mistaken  for  those  in  exacerbations
f  previous  cardiopulmonary  diseases,24 leading  to  delayed
iagnosis  and  treatment,  worse  prognosis  and  higher  mor-
ality.  Older  patients  are  more  complex,  and  may  have
igher  comorbidity  and  delayed  diagnosis24; comorbidity
as  also  been  suggested  as  a  risk  factor  for  PE  in  these
atients.25,26
The  clinical  signiﬁcance  of  subsegmental  PE  is  unknown.
owever,  it  may  have  clinical  relevance  and  long-term  con-
equences  in  patients  with  low  cardiopulmonary  reserve.2 It
sually  has  low  mortality2,27 and  a  good  prognosis.5,28 Thus,
 number  of  authors  have  suggested  that  certain  patients
ould  not  require  anticoagulant  therapy.29,30
Our  data  suggest  that  patients  with  subsegmental  PE
linically  differ  to  a  large  degree  from  those  with  more
roximal  PE.  The  prognosis  is  inﬂuenced  by  the  presence
f  accompanying  disorders  rather  than  by  the  extent  of  the
isease.M.T.  García-Sanz  et  al.
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